Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression.
Li H, Takayama K, Wang S, Shiraishi Y, Gotanda K, Harada T, Furuyama K, Iwama E, Ieiri I, Okamoto I, Nakanishi Y. Li H, et al. Among authors: shiraishi y. Cancer Chemother Pharmacol. 2014 Dec;74(6):1297-305. doi: 10.1007/s00280-014-2610-x. Epub 2014 Oct 26. Cancer Chemother Pharmacol. 2014. PMID: 25344762 Free PMC article.
Pleuropulmonary Paragonimiasis with Multiple Nodules in the Pleura.
Ogata H, Harada E, Moriya S, Fukuyama S, Suzuki K, Shiraishi Y, Ando H, Uryu K, Shinozaki S, Ide M, Sakamoto A, Nakanishi T, Hamada N, Yoneshima Y, Ota K, Kohashi K, Tateishi Y, Miyashita Y, Oda Y, Matsumoto K. Ogata H, et al. Among authors: shiraishi y. Intern Med. 2020 Aug 1;59(15):1879-1881. doi: 10.2169/internalmedicine.4457-20. Epub 2020 Apr 30. Intern Med. 2020. PMID: 32350198 Free PMC article.
Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Shiraishi Y, Kishimoto J, Tanaka K, Sugawara S, Daga H, Hirano K, Azuma K, Hataji O, Hayashi H, Tachihara M, Mitsudomi T, Seto T, Nakagawa K, Yamamoto N, Okamoto I. Shiraishi Y, et al. Clin Lung Cancer. 2020 Sep;21(5):472-476. doi: 10.1016/j.cllc.2020.03.010. Epub 2020 Apr 10. Clin Lung Cancer. 2020. PMID: 32381420 Clinical Trial.
Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer.
Inoue H, Tsutsumi H, Tanaka K, Iwama E, Shiraishi Y, Hirayama A, Nakanishi T, Ando H, Nakajima M, Shinozaki S, Ogata H, Uryu K, Okamura K, Kimura S, Ogawa T, Ota K, Yoneshima Y, Hamada N, Nakanishi Y, Okamoto I. Inoue H, et al. Among authors: shiraishi y. Transl Lung Cancer Res. 2021 Jun;10(6):2475-2486. doi: 10.21037/tlcr-21-92. Transl Lung Cancer Res. 2021. PMID: 34295655 Free PMC article.
1,430 results